promoter: a molecular mechanism of Tax transactivation. Mol Cell Biol 17: 5156–5164. 45. Kwok RP, Laurance ME, Lundblad JR, Goldman PS, Shih H, et al. (1996) Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP. Nature 380: 642–646. 46. Wu K, Bottazzi ME, de la Fuente C, Deng L, Gitlin SD, et al. (2004) Protein profile of tax-associated complexes. J Biol Chem 279: 495–508. 47. Kehn K, Fuente Cde L, Strouss K, Berro R, Jiang H, et al. (2005) The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degrada- tion. Oncogene 24: 525–540. 48. Rahman S, Quann K, Pandya D, Singh S, Khan ZK, et al. (2012) HTLV-1 Tax mediated downregulation of miRNAs associated with chromatin remodeling factors in T cells with stably integrated viral promoter. PLoS One 7: e34490. 49. Zheng ZM (2010) Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses. Int J Biol Sci 6: 730–755. 50. Coley W, Van Duyne R, Carpio L, Guendel I, Kehn-Hall K, et al. (2010) Absence of DICER in monocytes and its regulation by HIV-1. J Biol Chem 285: 31930–31943. 51. Robek MD, Ratner L (1999) Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J Virol 73: 4856–4865. 52. Lee WR, Yu XF, Syu WJ, Essex M, Lee TH (1992) Mutational analysis of conserved N-linked glycosylation sites of human immunodeficiency virus type 1 gp41. J Virol 66: 1799–1803. 53. Smith MR, Greene WC (1990) Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes Dev 4: 1875–1885. 54. Yamaoka S, Inoue H, Sakurai M, Sugiyama T, Hazama M, et al. (1996) Constitutive activation of NF-kappa B is essential for transformation of rat fibroblasts by the human T-cell leukemia virus type I Tax protein. EMBO J 15: 873–887. 55. Goren I, Semmes OJ, Jeang KT, Moelling K (1995) The amino terminus of Tax is required for interaction with the cyclic AMP response element binding protein. J Virol 69: 5806–5811. 56. Harrod R, Kuo YL, Tang Y, Yao Y, Vassilev A, et al. (2000) p300 and p300/ cAMP-responsive element-binding protein associated factor interact with human T-cell lymphotropic virus type-1 Tax in a multi-histone acetyltransferase/ activator-enhancer complex. J Biol Chem 275: 11852–11857. 57. Smith MR, Greene WC (1992) Characterization of a novel nuclear localization signal in the HTLV-I tax transactivator protein. Virology 187: 316–320. 58. Xiao G, Sun SC (2000) Activation of IKKalpha and IKKbeta through their fusion with HTLV-I tax protein. Oncogene 19: 5198–5203. 59. Basbous J, Bazarbachi A, Granier C, Devaux C, Mesnard JM (2003) The central region of human T-cell leukemia virus type 1 Tax protein contains distinct domains involved in subunit dimerization. J Virol 77: 13028–13035. 60. Gatza ML, Marriott SJ (2006) Genotoxic stress and cellular stress alter the subcellular distribution of human T-cell leukemia virus type 1 tax through a CRM1-dependent mechanism. J Virol 80: 6657–6668. 61. Fu DX, Kuo YL, Liu BY, Jeang KT, Giam CZ (2003) Human T-lymphotropic virus type I tax activates I-kappa B kinase by inhibiting I-kappa B kinase- associated serine/threonine protein phosphatase 2A. J Biol Chem 278: 1487– 1493. 62. Semmes OJ, Jeang KT (1995) Definition of a minimal activation domain in human T-cell leukemia virus type I Tax. J Virol 69: 1827–1833. 63. Alefantis T, Jain P, Ahuja J, Mostoller K, Wigdahl B (2005) HTLV-1 Tax nucleocytoplasmic shuttling, interaction with the secretory pathway, extracellu- lar signaling, and implications for neurologic disease. J Biomed Sci 12: 961–974. 64. Rousset R, Fabre S, Desbois C, Bantignies F, Jalinot P (1998) The C-terminus of the HTLV-1 Tax oncoprotein mediates interaction with the PDZ domain of cellular proteins. Oncogene 16: 643–654. 65. Chiari E, Lamsoul I, Lodewick J, Chopin C, Bex F, et al. (2004) Stable ubiquitination of human T-cell leukemia virus type 1 tax is required for proteasome binding. J Virol 78: 11823–11832. 66. Watashi K, Yeung ML, Starost MF, Hosmane RS, Jeang KT (2010) Identification of small molecules that suppress microRNA function and reverse tumorigenesis. J Biol Chem 285: 24707–24716. 67. Ruggero K, Corradin A, Zanovello P, Amadori A, Bronte V, et al. (2010) Role of microRNAs in HTLV-1 infection and transformation. Mol Aspects Med 31: 367–382. 68. Yoshida K, Seo Y, Yamasaki H, Tanoue K, Murakoshi N, et al. (2007) Effect of triangle ventricular pacing on haemodynamics and dyssynchrony in patients with advanced heart failure: a comparison study with conventional bi-ventricular pacing therapy. Eur Heart J 28: 2610–2619. 69. Jiang H, Lu H, Schiltz RL, Pise-Masison CA, Ogryzko VV, et al. (1999) PCAF interacts with tax and stimulates tax transactivation in a histone acetyltransfer- ase-independent manner. Mol Cell Biol 19: 8136–8145. 70. Lemasson I, Polakowski NJ, Laybourn PJ, Nyborg JK (2004) Transcription regulatory complexes bind the human T-cell leukemia virus 59 and 39 long terminal repeats to control gene expression. Mol Cell Biol 24: 6117–6126. HTLV-1 Tax and Drosha Interactions 71. Lenzmeier BA, Giebler HA, Nyborg JK (1998) Human T-cell leukemia virus type 1 Tax requires direct access to DNA for recruitment of CREB binding protein to the viral promoter. Mol Cell Biol 18: 721–731. 72. Xia T, O’Hara A, Araujo I, Barreto J, Carvalho E, et al. (2008) EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir- BHRF1–3. Cancer Res 68: 1436–1442. 73. Barth S, Pfuhl T, Mamiani A, Ehses C, Roemer K, et al. (2008) Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA poly- merase BALF5. Nucleic Acids Res 36: 666–675. 74. Choy EY, Siu KL, Kok KH, Lung RW, Tsang CM, et al. (2008) An Epstein- Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med 205: 2551–2560. 75. Lo AK, To KF, Lo KW, Lung RW, Hui JW, et al. (2007) Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc Natl Acad Sci U S A 104: 16164–16169. 76. Strebel K, Luban J, Jeang KT (2009) Human cellular restriction factors that target HIV-1 replication. BMC Med 7: 48. 77. Bennasser Y, Jeang KT (2006) HIV-1 Tat interaction with Dicer: requirement for RNA. Retrovirology 3: 95. 78. Bennasser Y, Le SY, Yeung ML, Jeang KT (2006) MicroRNAs in human immunodeficiency virus-1 infection. Methods Mol Biol 342: 241–253. 79. Bennasser Y, Yeung ML, Benkirane M, Jeang KT (2006) RNA interference and HIV-1: hits and misses. Curr Opin HIV AIDS 1: 208–211. 80. Haasnoot J, Westerhout EM, Berkhout B (2007) RNA interference against viruses: strike and counterstrike. Nat Biotechnol 25: 1435–1443. 81. Ballaun C, Farrington GK, Dobrovnik M, Rusche J, Hauber J, et al. (1991) Functional analysis of human T-cell leukemia virus type I rex-response element: direct RNA binding of Rex protein correlates with in vivo activity. J Virol 65: 4408–4413. 82. Kusuhara K, Anderson M, Pettiford SM, Green PL (1999) Human T-cell leukemia virus type 2 Rex protein increases stability and promotes nuclear to cytoplasmic transport of gag/pol and env RNAs. J Virol 73: 8112–8119. 83. Narayan M, Kusuhara K, Green PL (2001) Phosphorylation of two serine residues regulates human T-cell leukemia virus type 2 Rex function. J Virol 75: 8440–8448. 84. Satou Y, Nosaka K, Koya Y, Yasunaga JI, Toyokuni S, et al. (2004) Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro. Leukemia 18: 1357–1363. 85. Mitra-Kaushik S, Harding JC, Hess JL, Ratner L (2004) Effects of the proteasome inhibitor PS-341 on tumor growth in HTLV-1 Tax transgenic mice and Tax tumor transplants. Blood 104: 802–809. 86. Abou-Merhi R, Khoriaty R, Arnoult D, El Hajj H, Dbouk H, et al. (2007) PS- 341 or a combination of arsenic trioxide and interferon-alpha inhibit growth and induce caspase-dependent apoptosis in KSHV/HHV-8-infected primary effusion lymphoma cells. Leukemia 21: 1792–1801. 87. Nasr R, El-Sabban ME, Karam JA, Dbaibo G, Kfoury Y, et al. (2005) Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma. Onco- gene 24: 419–430. 88. Chowdhury IH, Radonovich M, Mahieux R, Pise-Masison C, Muralidhar S, et al. (2003) P53 facilitates degradation of human T-cell leukaemia virus type I Tax-binding protein through a proteasome-dependent pathway. J Gen Virol 84: 897–906. 89. Bellon M, Lepelletier Y, Hermine O, Nicot C (2009) Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. Blood 113: 4914–4917. 90. Pichler K, Schneider G, Grassmann R (2008) MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-trans- formed T lymphocytes. Retrovirology 5: 100. 91. Houzet L, Yeung ML, de Lame V, Desai D, Smith SM, et al. (2008) MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals. Retrovirology 5: 118. 92. Yeung ML, Bennasser Y, Watashi K, Le SY, Houzet L, et al. (2009) Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: evidence for the processing of a viral-cellular double-stranded RNA hybrid. Nucleic Acids Res 37: 6575–6586. 93. Chen R, Alvero AB, Silasi DA, Kelly MG, Fest S, et al. (2008) Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. Oncogene 27: 4712–4723. 94. Sakurai K, Furukawa C, Haraguchi T, Inada K, Shiogama K, et al. (2011) MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers. Cancer Res 71: 1680–1689. 95. Lagos D, Pollara G, Henderson S, Gratrix F, Fabani M, et al. (2010) miR-132 regulates antiviral innate immunity through suppression of the p300 transcrip- tional co-activator. Nat Cell Biol 12: 513–519. 96. O’Hara SP, Splinter PL, Gajdos GB, Trussoni CE, Fernandez-Zapico ME, et al. (2010) NFkappaB p50-CCAAT/enhancer-binding protein beta (C/EBPbeta)- mediated transcriptional repression of microRNA let-7i following microbial infection. J Biol Chem 285: 216–225. PLoS ONE | www.plosone.org 14 July 2012 | Volume 7 | Issue 7 | e40662